Search - tctmd.com

Displaying 741 - 760 of 911

Sort: Relevancy | Date

Presentation ACC 2013

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: Vinod H. Thourani

March 11, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

L.A. McKeown

March 11, 2013

News Industry News

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

March 09, 2013

News Daily News

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

Caitlin E. Cox

March 03, 2013

News Daily News

La Intervención Transcatéter Válvula Mitral dentro de Otra Válvula es Buena para los Pacientes Inoperables

Caitlin E. Cox

March 03, 2013

News Daily News

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

February 28, 2013

News Daily News

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

February 28, 2013

News Industry News

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

February 27, 2013

Presentation TCT 2013

Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis

Presenter: Sammy Elmariah, Jonathan Passeri, Irene Hueter, Ronan Margey, Ignacio Inglessis, Joshua Baker, Maureen Daher, Susheel Kodali, Praveen Mehrotra, Martin Leon, Lars Svensson, Arvind Agnihotri, Gus Vlahakes, Philippe Pibarot, Pamela Douglas, Igor Palacios

January 31, 2013

Presentation TCT 2013

One Year Outcomes following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients Over 75 Years ‘The Elderly Pilot Study’

Presenter: Alaide Chieffo, Gill Buchanan, Azeem Latib, Irene Franzoni, Matteo Montorfano, Francesco Maisano, Micaela Cioni, Filippo Figini, Eustachio Agricola, Giovanni La Canna, Remo Covello, Annalisa Franco, Chiara Gerli, Pietro Spagnolo, Ermelinda De Meo, Alessandro Durante, Angela Ferrari, Ottavio Alfieri, Antonio Colombo

January 31, 2013

Presentation TCT 2013

Is Transcatheter Aortic Valve Implantation A Cost-Effective Treatment in Patients Who Are Ineligible For Surgical Aortic Valve Replacement?

Presenter: Rachele Busca, James Eaton, Pascale Brasseur, Ruben L. J. Osnabrugge, Stuart Mealing

January 31, 2013

Presentation TCT 2013

Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith, Stephen Worthley, Robert Whitbourn, Paul Antonis, Joseph Montarello, Andrew Newcomb, Dominic Allocco, Keith Dawkins

January 31, 2013

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Caitlin E. Cox

November 12, 2012

Advertisement

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

La Intervención Transcatéter Válvula Mitral dentro de Otra Válvula es Buena para los Pacientes Inoperables

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis

One Year Outcomes following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients Over 75 Years ‘The Elderly Pilot Study’

Is Transcatheter Aortic Valve Implantation A Cost-Effective Treatment in Patients Who Are Ineligible For Surgical Aortic Valve Replacement?

Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Low BMI Predicts Stroke, Death After TAVR

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content